NCT05100329 2021-10-29
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
Clinical Trials
4 trialsNCT04928625 2021-08-24
A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04482257 2020-07-22
Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04239001 2020-01-23
Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase NA Unknown